What is Ava?
Ava is a digital health company dedicated to enhancing women's reproductive health. Operating from offices in Zurich, San Francisco, Belgrade, and Makati, the company leverages artificial intelligence and clinical research to provide personalized insights. Its core offering is a fertility tracking sensor bracelet that accurately detects a woman's five most fertile days in real-time, boasting 90% accuracy. This technology aims to empower women with greater understanding and control over their reproductive health and potential pregnancies.
How much funding has Ava raised?
Ava has raised a total of $42.3M across 3 funding rounds:
Angel/Seed
$2.6M
Series A
$9.7M
Series B
$30M
Angel/Seed (2015): $2.6M with participation from Swisscom and Zu00fcrcher Kantonalbank
Series A (2016): $9.7M led by Polytech Ventures, Blue Ocean Ventures, Global Sources, Zürcher Kantonalbank, and Swisscom
Series B (2018): $30M supported by Global Sources, Zürcher Kantonalbank, btov, Polytech Ventures, Blue Ocean Ventures, SVC Ltd., and Swisscom
Key Investors in Ava
Swisscom
Swisscom, a major Swiss telecommunications provider, has provided backing to Ava. Their involvement suggests a strategic interest in the intersection of technology and health services.
Zürcher Kantonalbank
Zürcher Kantonalbank, a leading Swiss universal bank, has invested in Ava, indicating a focus on innovative companies within the European market, particularly those with strong technological foundations.
btov
btov, a European venture firm specializing in early-stage investments, has supported Ava. Their investment aligns with their strategy of backing ambitious entrepreneurs and innovative ideas in sectors like healthcare technology.
What's next for Ava?
With the recent influx of major enterprise-level funding, Ava is poised for accelerated growth and market expansion. The company's focus on AI-driven reproductive health solutions places it at the forefront of a rapidly evolving digital health landscape. Future strategic initiatives are likely to involve further development of its AI algorithms, enhancement of its sensor technology, and broader market penetration. The substantial capital infusion will support scaling operations, expanding research and development efforts, and potentially exploring new applications within women's health, solidifying its role as a leader in this specialized sector.
See full Ava company page
